-
Mashup Score: 0Identifying The Appropriate Patient for IO Therapy in Advanced Non-Melanoma Skin Cancer - 18 hour(s) ago
In this segment, expert faculty explore the clinical considerations involved in selecting patients with aBCC and aCSCC for immuno-oncology (IO) therapy. Topics include evaluation criteria, comorbidities, patient characteristics, and the shared decision-making process between clinicians and patients when determining the suitability of IO therapy.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1The Role of IO Therapy in Advanced Non-Melanoma Skin Cancer - 2 day(s) ago
This roundtable video provides a comprehensive overview of advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. Experts discuss the current clinical treatment landscape, with a special focus on immuno-oncology (IO) therapies.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
Unlocking the Power of IO Therapy in Advanced NMSC Experts break down the evolving treatment landscape for aBCC & aCSCC, spotlighting IO therapy and clinical trial data driving better outcomes for advanced cases. https://t.co/6UufSG20iL #SkinCancer #Dermatology #aBCC #aCSCC https://t.co/wYun3Db0Nm
-
-
Mashup Score: 9Hemodynamic Rounds Live - 2 day(s) ago
Basic Listing Hemodynamic Rounds Live from Cath Lab Digest including Teaching Collection
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
No one teaches hemodynamics like Dr. Kern! 10 FREE videos with @MortKernMD include LA and Mitral Valve Hemodynamics, Primer on LV Function, and The Stenotic Aortic Valve Part I and II. More: https://t.co/cZFPltef8a https://t.co/ngb2dXwuym
-
-
Mashup Score: 0Quadruplet Therapy Demonstrates Efficacy for Treatment of Transplant-Ineligible Newly Diagnosed Multiple Myeloma - 3 day(s) ago
Quadruplet therapy with isatuximab, weekly bortezomib, lenalidomide, and limited dexamethasone demonstrated safety and efficacy for older patients with transplant-ineligible MM in a phase 2 clinical trial.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
Quadruplet therapy with #isatuximab, weekly bortezomib, lenalidomide, and limited #dexamethasone demonstrated safety and efficacy for older patients with transplant-ineligible #MM in a phase 2 clinical trial. Learn more: https://t.co/oAcmudqowA https://t.co/CMkAm1Mvif
-
-
Mashup Score: 1Operational and Logistical Considerations With IO Therapy for Advanced Non-Melanoma Skin Cancer - 3 day(s) ago
In this final roundtable discussion, speakers discuss the operational and logistical aspects of delivering immuno-oncology (IO) therapy for patients with advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
🎥 IO Therapy in Practice: What You Need to Know Explore key operational insights for delivering IO therapy in advanced non-melanoma skin cancer—from infusion logistics to multidisciplinary coordination. https://t.co/nMYa4Lwb1s #SkinCancerCare #IOtherapy #DermOnc #aBCC #aCSCC
-
-
Mashup Score: 1
Dorys Chavez, MD, and colleagues explore the key challenges in diagnosis, risk stratification, pharmacology, procedural interventions, and management of atrial fibrillation in the long term.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
Key Challenges in Atrial Fibrillation: Diagnosis, Risk Stratification, and Treatment Dorys Chavez, MD, and colleagues review challenges in the diagnosis, risk stratification, pharmacology, procedural interventions, and management of #AFib. https://t.co/Nct6hcDXjL https://t.co/TcR6MCsntQ
-
-
Mashup Score: 0
Drs. Bhattad and Hannan review coronary artery fistula management and identification, and share videos of a coronary artery fistula encountered as an incidental finding.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
Coronary Fistula: Left Anterior Descending to Pulmonary Artery Fistula Drs. Bhattad and Hannan review coronary artery fistula management and identification, and share videos of a coronary artery fistula encountered as an incidental finding. https://t.co/g30ZmdVu2C https://t.co/s9JZgU9jPX
-
-
Mashup Score: 0Tegafur-Uracil Maintenance Did Not Improve Survival for Patients With Locally Advanced Cervical Cancer - 3 day(s) ago
According to results from the phase 3 GOTIC-002 trial, low-dose tegafur-uracil maintenance therapy did not improve survival among patients with locally advanced cervical cancer.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
According to results from the phase 3 GOTIC-002 trial, low-dose tegafur-uracil maintenance therapy did not improve survival among patients with locally advanced cervical cancer. Learn more: https://t.co/dMiQM54Vgo #medtwitter #onctwitter https://t.co/7v86ceUBUQ
-
-
Mashup Score: 0Advancements in Treatment Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma - 4 day(s) ago
Nilanjan Ghosh, MD, PhD, FACP discusses new updates in treatment strategies for patients with relapsed/refractory diffuse large B-cell lymphoma including bispecific antibodies and CAR T-cell therapy.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine NewsTweet-
Nilanjan Ghosh, MD, PhD, FACP discusses new updates in treatment strategies for patients with relapsed/refractory #DLBCL including bispecific #antibodies and CAR T-cell therapy. Learn more: https://t.co/jUnbRapu4g https://t.co/7dfHI22Qxs
-
-
Mashup Score: 2Real-World Case Studies and Insights on IO Therapy for Advanced Non-Melanoma Skin Cancer - 4 day(s) ago
This video presents real-world patient cases from each of the three expert speakers, illustrating the practical use of immuno-oncology (IO) therapy in treating advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet-
Insights on IO Therapy for aNMSC Watch expert-led case studies on advanced basal & cutaneous squamous cell carcinoma, highlighting personalized treatment strategies, clinical decision-making, and post-treatment care. https://t.co/l6kQuivaYf #SkinCancer #aBCC #aCSCC #Dermatology
-
Right Fit for IO Therapy In this expert video, learn how clinicians identify appropriate patients with aBCC & aCSCC for IO therapy, covering comorbidities, clinical criteria, and shared decision-making power. https://t.co/QWoxymPXNw #SkinCancer #Dermatology #aBCC #aCSCC https://t.co/k7FEXnjBBm